Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/1/2025

Methotrexate Safety and Monitoring Guidelines

Methotrexate Monitoring Recommendations

  • When using methotrexate, standard monitoring includes complete blood count (CBC) and platelet counts initially every 2-4 weeks for the first few months, then every 1-3 months, liver function tests (LFTs) at monthly intervals, and BUN and creatinine every 2-3 months. 1, 2

  • Folic acid supplementation (1-5 mg daily except on methotrexate dosing days) is recommended to reduce methotrexate side effects. 1, 2

Methotrexate Drug Interactions

  • Methotrexate has documented interactions with hepatotoxic drugs that should be avoided. 3, 1

  • Drugs that interfere with renal secretion of methotrexate (e.g., NSAIDs, penicillins, sulfamethoxazole) should be used with caution. 1

  • Folic acid antagonists (e.g., trimethoprim) should be avoided when taking methotrexate. 1

Special Precautions

  • In patients with renal impairment, methotrexate should be used with caution as it has some degree of renal elimination. 4

  • Elderly patients may require closer monitoring due to age-related changes in drug metabolism and elimination. 4

  • Maintain adequate hydration in patients on methotrexate to ensure proper drug elimination. 4

Bactrim-Methotrexate Interaction Guidelines

Introduction to Interaction Risks

  • High-dose Bactrim (800 mg/160 mg twice daily) poses a significant risk when used with methotrexate and should be avoided entirely, as recommended by the American College of Rheumatology guidelines, due to the potential for severe pancytopenia, mucositis, and renal toxicity 5, 6, 7
  • The American College of Rheumatology guidelines note that prophylactic dosing of Bactrim (single-strength daily or double-strength three times weekly) is generally tolerated but requires close monitoring when used with methotrexate 5, 6, 7

Clinical Considerations for Concurrent Use

  • Pneumocystis jirovecii pneumonia prophylaxis is the primary indication where concurrent use of Bactrim and methotrexate may be justified, particularly in patients on high-dose corticosteroids or rituximab, as stated in the 2021 American College of Rheumatology guidelines 5, 6
  • For Pneumocystis prophylaxis, consider alternative agents such as atovaquone or dapsone (after G6PD screening) to avoid the Bactrim-methotrexate interaction entirely, as suggested by the American College of Rheumatology 5